News Solid Biosciences acquires AavantiBio, conducts $75 million ... The life sciences company Solid Biosciences is merging with the privately-held gene therapy company AavantiBio in a
Digital Digital therapeutics at a turning point: What we heard at DT... This year the digital therapeutics space took a hit with the downfall of Pear Therapeutics,
R&D Turning drug development on its head Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho